申请人:The Upjohn Company
公开号:US04008326A1
公开(公告)日:1977-02-15
A method of improving the endogenous production of prostaglandins by a mammal is disclosed, which comprises administering to the mammal an effective amount of 1-pyridylalkyl-3-naphthyl-2(thio)ureas. Disclosed also are novel substituted 1-pyridylalkyl-3-naphthyl-2(thio)ureas and therapeutic compositions thereof which are useful in carrying out the method of the invention. Disclosed also are methods of treating mammals for clinical conditions responsive to prostaglandins, such as, for example, male infertility, epidermal injuries, atonic uterine bleeding, thromboembolic disease and like clinical conditions.
揭示了一种通过给哺乳动物投与有效量的1-吡啶基烷基-3-萘基-2(硫)脲来改善前列腺素内源产生的方法。还揭示了新的取代的1-吡啶基烷基-3-萘基-2(硫)脲及其治疗组合物,这些组合物在执行该发明方法中非常有用。还揭示了治疗哺乳动物对前列腺素敏感的临床病症的方法,例如男性不育症、表皮损伤、子宫萎缩性出血、血栓栓塞性疾病等临床病症。